🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out whether the new drug PX-866 will s...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2011-09-09
Trial ID
NCT01331083
Treatments Being Tested
This study is being conducted to determine the safety and maximally tolerat...
Status
Completed
Location
University of Colorado Health Sciences Center
Start Date
2008-06
Trial ID
NCT00726583
Treatments Being Tested
The purpose of this Phase 1/2 open-label study is to determine the safety a...
Status
Completed
Location
Birmingham Hematology and Oncology Assocs.
Start Date
2010-12
Trial ID
NCT01252628
Treatments Being Tested
This is a two part study designed to evaluate the PK profile of PX-866 caps...
Status
Completed
Location
Comprehensive Clinical Development NW
Start Date
2011-07
Trial ID
NCT01408316
Treatments Being Tested
Phase 1: To determine the maximally tolerated dose (MTD) or recommended dos...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-09
Trial ID
NCT01204099
The purpose of this study is to find out whether the new drug PX-866 will s...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2011-04-01
Trial ID
NCT01259869
Treatments Being Tested
The purpose of the phase 1 portion of the study is to determine the maximal...
Status
Terminated
Location
H. Lee Moffitt Cancer Center
Start Date
2012-08
Trial ID
NCT01616199
Treatments Being Tested